We use cookies to provide you with a better experience. By continuing to browse the site you are agreeing to our use of cookies in accordance with our Cookie Policy.
Accept
Home » Blincyto Patients Show Leukemia Remission, Amgen Claims
Blincyto Patients Show Leukemia Remission, Amgen Claims
Amgen is reporting a “clinically meaningful number” of patients showed complete remission in a Phase 2 study of its pricey drug to treat a rare strain of leukemia.